Search research articles
Contact Us
Filters
Showing results (81-90 of 194) with videos related to
Page
of 20
Sort By:
Zeitschrift Fur Medizinische Physik
|
July 19, 2015
Three-dimensional versus four-dimensional dose calculation for volumetric modulated arc therapy of hypofractionated treatments
Stefanie Ehrbar, Stephanie Lang, Sonja Stieb, et al.
Oncotarget
|
April 21, 2017
The hypoxia-activated prodrug evofosfamide in combination with multiple regimens of radiotherapy
Katarzyna J Nytko, Ivo Grgic, Sabine Bender, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 23, 2017
Comparison of multi-leaf collimator tracking and treatment-couch tracking during stereotactic body radiation therapy of prostate cancer
Stefanie Ehrbar, Simon Schmid, Alexander Jöhl, et al.
Interactive Cardiovascular and Thoracic Surgery
|
December 28, 2018
Accuracy of deployment of the Relay non-bare stent graft in the aortic arch
Tatjana Riesterer, Friedhelm Beyersdorf, Johannes Scheumann, et al.
Acta Oncologica (Stockholm, Sweden)
|
August 19, 2017
Comparison of PET and CT radiomics for prediction of local tumor control in head and neck squamous cell carcinoma
Marta Bogowicz, Oliver Riesterer, Luisa Sabrina Stark, et al.
Neuroradiology
|
April 6, 2019
Dependency of the blood oxygen level dependent-response to hyperoxic challenges on the order of gas administration in intracranial malignancies
Sonja Stieb, Oliver Riesterer, Andreas Boss, et al.
Chemmedchem
|
March 16, 2010
Azides derived from colchicine and their use in library synthesis: A practical entry to new bioactive derivatives of an old natural drug
Norman Nicolaus, Janet Zapke, Philipp Riesterer, et al.
Radiation Oncology (London, England)
|
February 13, 2019
3-weekly or weekly cisplatin concurrently with radiotherapy for patients with squamous cell carcinoma of the head and neck - a multicentre, retrospective analysis
Seth Helfenstein, Oliver Riesterer, Urs R Meier, et al.
Investigational New Drugs
|
December 22, 2009
A novel Chk inhibitor, XL-844, increases human cancer cell radiosensitivity through promotion of mitotic catastrophe
Oliver Riesterer, Fumihiko Matsumoto, Li Wang, et al.
Scandinavian Journal of Rheumatology. Supplement
|
January 1, 1978
Pharmacological properties of diclofenac sodium and its metabolites
R Menassé, P R Hedwall, J Kraetz, et al.
Page
of 20
Search research articles
Search
Showing results (81-90 of 194) with videos related to
Sort By:
Page
of 20
Zeitschrift Fur Medizinische Physik
|
July 19, 2015
Three-dimensional versus four-dimensional dose calculation for volumetric modulated arc therapy of hypofractionated treatments
Stefanie Ehrbar, Stephanie Lang, Sonja Stieb, et al.
Oncotarget
|
April 21, 2017
The hypoxia-activated prodrug evofosfamide in combination with multiple regimens of radiotherapy
Katarzyna J Nytko, Ivo Grgic, Sabine Bender, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 23, 2017
Comparison of multi-leaf collimator tracking and treatment-couch tracking during stereotactic body radiation therapy of prostate cancer
Stefanie Ehrbar, Simon Schmid, Alexander Jöhl, et al.
Interactive Cardiovascular and Thoracic Surgery
|
December 28, 2018
Accuracy of deployment of the Relay non-bare stent graft in the aortic arch
Tatjana Riesterer, Friedhelm Beyersdorf, Johannes Scheumann, et al.
Acta Oncologica (Stockholm, Sweden)
|
August 19, 2017
Comparison of PET and CT radiomics for prediction of local tumor control in head and neck squamous cell carcinoma
Marta Bogowicz, Oliver Riesterer, Luisa Sabrina Stark, et al.
Neuroradiology
|
April 6, 2019
Dependency of the blood oxygen level dependent-response to hyperoxic challenges on the order of gas administration in intracranial malignancies
Sonja Stieb, Oliver Riesterer, Andreas Boss, et al.
Chemmedchem
|
March 16, 2010
Azides derived from colchicine and their use in library synthesis: A practical entry to new bioactive derivatives of an old natural drug
Norman Nicolaus, Janet Zapke, Philipp Riesterer, et al.
Radiation Oncology (London, England)
|
February 13, 2019
3-weekly or weekly cisplatin concurrently with radiotherapy for patients with squamous cell carcinoma of the head and neck - a multicentre, retrospective analysis
Seth Helfenstein, Oliver Riesterer, Urs R Meier, et al.
Investigational New Drugs
|
December 22, 2009
A novel Chk inhibitor, XL-844, increases human cancer cell radiosensitivity through promotion of mitotic catastrophe
Oliver Riesterer, Fumihiko Matsumoto, Li Wang, et al.
Scandinavian Journal of Rheumatology. Supplement
|
January 1, 1978
Pharmacological properties of diclofenac sodium and its metabolites
R Menassé, P R Hedwall, J Kraetz, et al.
Page
of 20